Stockreport

CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Encouraged to Contact the Firm

Cerevel Therapeutics Holdings, Inc.  (CERE) 
PDF NEW YORK, June 22, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq [Read more]